NEW ORLEANS, Aug. 17, 2026 /PRNewswire/ -- 28bio today launched CNS-3D Plasticity Organoids, enabling human functional endpoints of learning and memory before drug candidates enter clinical testing.
The blood-brain barrier functions as a tightly regulated biological filter, shielding brain tissue from harmful substances traveling through the bloodstream. While this defense mechanism is vital for ...
This episode of the Pharmaron DMPK Insights Podcast Series sees Scott Summerfield (Senior Director and Head of Pharmaceutical Metabolism at Pharmaron) and Professor Elizabeth de Lange Professor in ...
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this ...
Lipid nanoparticles have shown success in targeting major organs such as the liver, spleen, and lungs, but crossing the blood-brain barrier (BBB) remains a major challenge. Effective brain-targeted ...
Praxis Precision Medicines, Inc. (PRAX) stock is soaring in trading today, up 35% at time of writing, with shares reaching a value of $260, their highest value since the beginning of 2022. Current ...
In this open-label Phase 1b study (NCT06395285), six adult patients with genetically confirmed ROSAH syndrome completed 28 days of once-daily oral DF-003 treatment followed by post-treatment ...
Despite years of guidelines cautioning against their use, potentially inappropriate central nervous system (CNS)-active medications are commonly prescribed to older adults —particularly those with ...
Lunai Bioworks Inc. (NASDAQ:LNAI) said it has signed a binding agreement to purchase blood-brain barrier delivery technology and central nervous system Alzheimer’s drug assets from Clemann Group, SAS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results